The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: A randomized placebo-controlled trial

Nicola A. Hanania, Gregory Feldman, Wolfgang Zachgo, Jae Jeong Shim, Courtney Crim, Lisa Sanford, Sally Lettis, Frank Barnhart, Brett Haumann

Research output: Contribution to journalArticlepeer-review

84 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The efficacy and safety of the novel long-acting β<sub>2</sub> agonist vilanterol in patients with COPD: A randomized placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences